Additionally, 4-OI treatment reduced the percentage of TNF+ CD8+ and IFN-γ+ CD8+ tumor-infiltrating T cells in WT mice and led to no difference in the cytotoxic capacity of CD8+ T cells between WT and KO mice (Supplementary Fig. 3c). The gene discussed is CD8A; the disease is neoplasm.